(Circulation. 1997;96:3266-3268.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Medicine, Danderyd Hospital (P.L.), Stockholm, Sweden, and the Departments of Thoracic Physiology (M.E.) and Cardiology (K.S.-G., P.T.) and Atherosclerosis Research Unit at King Gustaf V Research Institute (P.L., F.K., P.T.), Karolinska Hospital, Stockholm, Sweden.
Correspondence to Dr Per Tornvall, Department of Cardiology, Karolinska Hospital, S-171 76 Stockholm, Sweden.
| Abstract |
|---|
|
|
|---|
Methods and Results Flow- and nitroglycerin-induced dilatation of the brachial artery was investigated noninvasively by high-resolution ultrasound technique in seven young, healthy men without risk factors for coronary heart disease. Transient triglyceridemia was induced by infusion of a triglyceride emulsion, Intralipid, which raised free fatty acid concentrations twofold and triglyceride levels fourfold. Flow-induced vasodilatation decreased from 7.1±3.0% to 1.6±2.6% (P<.0002), whereas nitroglycerin-induced vasodilatation decreased from 20.5±5.8% to 11.5±3.2% (P<.002) before and after 1 hour of infusion of Intralipid, respectively.
Conclusions Transient triglyceridemia decreases vascular reactivity, presumably by both endothelium-dependent and endothelium-independent mechanisms.
Key Words: triglyceridemia coronary disease vasodilation
| Introduction |
|---|
|
|
|---|
Previously, investigators of endothelial dysfunction in hyperlipidemia have focused on hypercholesterolemia. However, there is a lack of studies of hypertriglyceridemia, which also is considered a risk factor for CHD,7 although the mechanism behind the increased risk is less well understood. To find out whether triglyceridemia affects endothelial function, we examined flow- and nitroglycerin (NTG)-induced vasodilatation of the brachial artery noninvasively by high-resolution ultrasound technique in young, healthy men without risk factors for CHD. Infusion of a triglyceride emulsion, Intralipid, was chosen to give a reproducible transient triglyceridemia without the possible interference of carbohydrate-induced hyperinsulinemia.
| Methods |
|---|
|
|
|---|
All subjects were studied on two separate occasions at least 4 hours after a light breakfast. First, the response to flow-induced vasodilatation was measured twice before and once after 1 hour of infusion of Intralipid. The experiment was terminated by measurement of vasodilatation in response to 0.4 mg of buccal NTG. Because of the poor response to NTG in the first series of experiments in comparison with the results reported by Celermajer and coworkers,8 a second series of experiments was made in which the response to both flow- and NTG-induced vasodilatation was investigated before and after 1 hour of infusion of Intralipid. Intralipid (Pharmacia-Upjohn) was given as a bolus of 0.15 g/kg body wt followed by continuous infusion of 0.15 g · kg-1 · h-1 until the experiment was finished.
The study was approved by the local Ethics Committee at the Karolinska Hospital.
Ultrasound Technique and Lipid Determinations
Endothelium-dependent flow-induced and
endothelium-independent NTG-induced dilatation of the
left brachial artery were measured noninvasively by high-resolution
ultrasound Doppler technique.8 All ultrasound
scans were made with Acuson 128 XP/10 equipped with a 7-MHz ART linear
array transducer. The subjects were examined after 30 minutes at rest
in a quiet, dark room with a temperature of 22°C to 23°C. The
brachial artery was scanned longitudinally 2 to 10 cm above the elbow,
and the transducer was held in the same position during the experiment
by a special device. The baseline measurements of blood flow and the ID
of the brachial artery were taken at rest and 1 minute after reactive
hyperemia (RH) provoked by distal forearm artery occlusion with
a 12.5-cm-wide blood pressure cuff placed on the forearm and inflated
up to 300 mm Hg for 4.5 minutes, followed by release. The
subjects then rested for 10 minutes. New ultrasound measurements were
performed after a new RH or 4 minutes after administration of 0.4 mg
buccal NTG. All measurements of the ID of the brachial artery were
performed with the investigator blinded to the sequence of the
recordings. The variation in differences between flow-induced
vasodilatation determined twice during the same day and between three
determinations on separate days were 0.88±0.82% and 3.34±2.68%,
respectively.
Blood samples were drawn into vacuum tubes containing 1.4 mg Na2-EDTA/mL before and during the infusion of Intralipid. Baseline samples were drawn before the first ultrasound measurement and then repeated after 30, 60, and 90 minutes during the infusion. Plasma was recovered after low-speed centrifugation at 3000 rpm for 15 minutes and immediately frozen at -20°C. Triglyceride, cholesterol, and free fatty acid concentrations were determined after extraction9,10 by chemical methods1113 on thawed samples.
Statistical Methods
Values are expressed as mean±SD. Statistical testing of
differences between flow- and NTG-induced vasodilatation before and
after 1 hour of infusion of Intralipid was made by Student's paired
t test and ANOVA.
| Results |
|---|
|
|
|---|
|
In the first series of experiments, RH induced by occlusion of
the distal forearm resulted in an increase in the ID of the brachial
artery by 7.1±3.0%, from 3.91±0.52 to 4.18±0.53 mm. After 1
hour of infusion of Intralipid, flow-induced vasodilatation was only
1.6±2.6%, increasing from 3.96±0.58 to 4.02±0.56 mm
(P<.0002, Student's paired t test), compared
with vasodilatation before infusion (Fig 2A
). NTG-induced vasodilatation after
infusion of Intralipid was 13.8±3.8%. In the second series of
experiments, administration of 0.4 mg of buccal NTG resulted in an
increase in the ID of the brachial artery by 20.5±5.8%, from
3.77±0.49 to 4.55±0.67 mm. After 1 hour of infusion of
Intralipid, NTG-induced vasodilatation was only 11.5±3.2%, increasing
from 4.01±0.54 to 4.47±0.68 mm (P<.002, ANOVA),
compared with vasodilatation before infusion (Fig 2B
). If the increase
in ID of the brachial artery after NTG was related to the baseline
diameter before the start of the infusion of Intralipid, the increase
was 18.5±0.7% (P=NS) compared with vasodilatation before
infusion. Flow-induced dilatation of the brachial artery was
investigated also in the second series of experiments with results
similar to those in the first series, resulting in a decrease in
dilatation of the brachial artery from 7.4±2.0% to 2.3±2.1% before
and after 1 hour of infusion of Intralipid, respectively
(P<.0005, ANOVA).
|
| Discussion |
|---|
|
|
|---|
Our hypothesis was that plasma triglycerides or their catabolites free fatty acids formed during lipolysis at the endothelial surface would impair endothelium-dependent vasodilatation. To our surprise, however, the results showed that infusion of Intralipid decreased both flow- and NTG-induced dilatation of the brachial artery. Unfortunately, there was a drift in baseline ID of the brachial artery in the second series of experiments that might have influenced the results of NTG-induced vasodilatation. Therefore, it cannot be ascertained from the present results whether the impairment of vascular reactivity is endothelium-dependent or endothelium-independent. Presumably, the effect of transient triglyceridemia on brachial artery dilatation is both endothelium-dependent and endothelium-independent.
The cause of the decreased vasoreactivity after infusion of Intralipid is not clear but certainly includes effects of triglycerides or free fatty acids, which both increase in plasma during the infusion. It can be speculated that the increased concentrations of lipids inside and subintimal to the endothelium might decrease the diffusion of NO, causing spontaneous degradation before NO reaches the smooth vasculature. Furthermore, the increased concentrations of free fatty acid might inactivate NO by oxidative mechanisms. Other possible mechanisms include interference of free fatty acids with the synthesis of prostaglandins, resulting in an imbalance between vasoconstrictive and vasodilating substances.
The results of the present study might have several clinical implications. First, the increase in triglyceride and free fatty acid concentrations acquired during infusion of Intralipid is of a magnitude similar to the changes after a fatty meal. A decrease in the ability to vasodilate coronary arteries after a fatty meal on stimuli such as exercise could explain the phenomenon of postalimentary angina pectoris in patients with known coronary artery disease.14 Second, intensive care patients receiving parenteral nutrition with Intralipid would clearly not benefit from the inability to vasodilate on endogenous as well as exogenous stimuli.
The use of infusion of an artificial lipid emulsion such as Intralipid to increase the concentrations of triglyceride and free fatty acid is a possible limitation to the study. Another approach would have been to examine vasoreactivity of the brachial artery after the ingestion of a fatty meal. The latter was adopted by Vogel and coworkers,15 who showed that flow-induced dilatation of the brachial artery was impaired after intake of a fatty meal and that the increase in triglycerides correlated with the decrease in vasodilatation. However, they did not exclude an effect on endothelium-independent mechanisms, with the exception of a subgroup consisting of four individuals examined only once after intake of the fatty meal. The advantage of our approach is that the vascular effects of triglycerides and free fatty acids can be investigated without disturbances of vasoactive hormones, such as insulin, which increase after a fatty meal. In addition, the rise in triglyceride and free fatty acid concentrations after infusion of Intralipid is more reproducible than after a fatty meal.
Further support for the results of the present study comes from investigations of patients with noninsulin-dependent diabetes mellitus,5,6 which showed an impairment in both endothelium-dependent and endothelium-independent forearm blood flow compared with healthy control subjects. In fact, in the study by Watts and coworkers,6 this impairment was associated with increased triglyceride concentrations. In contrast, in a study by Chowienczyk and coworkers,16 patients with severe hypertriglyc-eridemia due to lack of lipoprotein lipase showed no impairment in forearm blood flow compared with normolipidemic control subjects. The discrepancy between the results of the present study and the study by Chowienczyk might indeed be explained by the lack of lipoprotein lipase at the endothelial surface, resulting in decreased generation and concentration of free fatty acid at this site, indicating a role for free fatty acids in the decreased vascular reactivity found in our study.
In summary, the results of the present study showed that transient triglyceridemia decreased vascular reactivity in the brachial artery in young, healthy men without risk factors for CHD. Further studies are needed to examine the role of triglycerides versus free fatty acids and to study the mechanisms behind the impairment in vascular reactivity. There is also a need to study whether this occurs in coronary arteries and in chronic hypertriglyceridemia.
| Acknowledgments |
|---|
Received August 27, 1997; revision received September 18, 1997; accepted September 23, 1997.
| References |
|---|
|
|
|---|
2.
Zeiher AM, Schächinger V, Hohnloser SH, Saurbier
B, Just H. Coronary atherosclerotic wall thickening and
vascular reactivity in humans. Circulation. 1994;89:25252532.
3. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B74B.[Medline] [Order article via Infotrieve]
4. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:14681474.[Abstract]
5. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567574.[Abstract]
6. Watts GF, O'Brien SF, Silvester W, Millar JA. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci. 1996;91:567573.[Medline] [Order article via Infotrieve]
7.
Austin MA. Plasma triglyceride and
coronary heart disease. Arterioscler Thromb. 1991;11:214.
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:11111115.[Medline] [Order article via Infotrieve]
9. Carlson LA. Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol. Clin Chim Acta. 1985;149:8993.[Medline] [Order article via Infotrieve]
10. Dole VPJ. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956;35:150154.
11. Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968;22:393397.[Medline] [Order article via Infotrieve]
12. Zlatkis A, Zak B, Boyle AJ. A new method for determination of serum cholesterol. J Lab Clin. 1953;41:486492.[Medline] [Order article via Infotrieve]
13. Ho RJ. Radiochemical assay of long chain fatty acids using 63Ni as tracer. Anal Biochem. 1970;36:105113.[Medline] [Order article via Infotrieve]
14. Gersh BJ, Braunwald E, Rutherford JD. Chronic coronary artery disease. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Fifth ed. Philadelphia, Pa: WB Saunders Co; 1997:1294.
15. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350354.[Medline] [Order article via Infotrieve]
16. Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol. 1997;29:964968.[Abstract]
This article has been cited by other articles:
![]() |
J. P. Crandall, H. Shamoon, H. W. Cohen, M. Reid, S. Gajavelli, G. Trandafirescu, V. Tabatabaie, and N. Barzilai Post-Challenge Hyperglycemia in Older Adults Is Associated with Increased Cardiovascular Risk Profile J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1595 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R. Gill, T. L. Pedersen, L. J. Higgins, J. W. Newman, and J. C. Rutledge Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation J. Lipid Res., February 1, 2009; 50(2): 204 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, A. R. Sapuri-Butti, H. H. Aung, A. N. Parikh, and J. C. Rutledge Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H237 - H244. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. F. Nascimento, L. M. A. Lessa, M. R. Kerntopf, C. M. Sousa, R. S. Alves, M. G. R. Queiroz, J. Price, D. B. Heimark, J. Larner, X. Du, et al. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide PNAS, January 3, 2006; 103(1): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
D H Hsi, A Roshandel, N Singh, T Szombathy, and Z S Meszaros Headache response to glyceryl trinitrate in patients with and without obstructive coronary artery disease Heart, September 1, 2005; 91(9): 1164 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Anderson, G. R Ellis, L. M. Evans, K. Morris, Y. Y Chirkov, J. D Horowitz, S. K Jackson, A. Rees, M. J Lewis, and M. P Frenneaux Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes Diabetes and Vascular Disease Research, May 1, 2005; 2(2): 88 - 93. [Abstract] [PDF] |
||||
![]() |
C. Giannattasio, A. Zoppo, G. Gentile, M. Failla, A. Capra, F.M. Maggi, A. Catapano, and G. Mancia Acute Effect of High-Fat Meal on Endothelial Function in Moderately Dyslipidemic Subjects Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 406 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Ferreira, A. A. Peter, A. J. Mendez, J. J. Jimenez, L. M. Mauro, J. A. Chirinos, R. Ghany, S. Virani, S. Garcia, L. L. Horstman, et al. Postprandial Hypertriglyceridemia Increases Circulating Levels of Endothelial Cell Microparticles Circulation, December 7, 2004; 110(23): 3599 - 3603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tsutsui, F. Xie, M. Cano, J. Chomas, P. Phillips, S. J. Radio, J. Lof, and T. R. Porter Detection of retained microbubbles in carotid arteries with real-time low mechanical index imaging in the setting of endothelial dysfunction J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1036 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Sposito, P. A. Lemos, R. D. Santos, W. Hueb, C. G. C. Vinagre, E. Quintella, O. Carneiro, M. J. Chapman, J. A. F. Ramires, and R. C. Maranhao Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: A long-term follow-up study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2225 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Maggi, S. Raselli, L. Grigore, L. Redaelli, S. Fantappie, and A. L. Catapano Lipoprotein Remnants and Endothelial Dysfunction in the Postprandial Phase J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2946 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gertow, M. Bellanda, P. Eriksson, S. Boquist, A. Hamsten, M. Sunnerhagen, and R. M. Fisher Genetic and Structural Evaluation of Fatty Acid Transport Protein-4 in Relation to Markers of the Insulin Resistance Syndrome J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 392 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D. Norata, A. Pirillo, E. Callegari, A. Hamsten, A.L. Catapano, and P. Eriksson Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL Cardiovasc Res, July 1, 2003; 59(1): 169 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Capell, C. A. DeSouza, P. Poirier, M. L. Bell, B. L. Stauffer, K. M. Weil, T. L. Hernandez, and R. H. Eckel Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 307 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Esposito, F. Nappo, F. Giugliano, G. Giugliano, R. Marfella, and D. Giugliano Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects Am. J. Clinical Nutrition, January 1, 2003; 77(1): 139 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-s. Zhong, X.-h. Lu, B. S. Conklin, P. H. Lin, A. B. Lumsden, Q. Yao, and C. Chen HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brotman and D. S. Ludwig Effects of Counterregulatory Hormones in a High-Glycemic Index Diet JAMA, August 14, 2002; 288(6): 695 - 695. [Full Text] [PDF] |
||||
![]() |
T. Hozumi, M. Eisenberg, K. Sugioka, A. R. Kokkirala, H. Watanabe, M. Teragaki, J. Yoshikawa, and S. Homma Change in Coronary Flow Reserve on Transthoracic Doppler Echocardiography after a Single High-Fat Meal in Young Healthy Men Ann Intern Med, April 2, 2002; 136(7): 523 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bohm, G. Ahlborg, B.-L. Johansson, L.-O. Hansson, and J. Pernow Combined Endothelin Receptor Blockade Evokes Enhanced Vasodilatation in Patients With Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.J.A.M Jonkers, M.A van de Ree, A.H.M Smelt, F.H.A.F de Man, H Jansen, A.E Meinders, A van der Laarse, and G.J Blauw Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia Cardiovasc Res, February 1, 2002; 53(2): 496 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Rim, H. Leong-Poi, J. R. Lindner, K. Wei, N. G. Fisher, and S. Kaul Decrease in Coronary Blood Flow Reserve During Hyperlipidemia Is Secondary to an Increase in Blood Viscosity Circulation, November 27, 2001; 104(22): 2704 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stein, M. A. Klein, J. L. Bellehumeur, P. E. McBride, D. A. Wiebe, J. D. Otvos, and J. M. Sosman Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction Circulation, July 17, 2001; 104(3): 257 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lundman, M. J. Eriksson, M. Stuhlinger, J. P. Cooke, A. Hamsten, and P. Tornvall Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine J. Am. Coll. Cardiol., July 1, 2001; 38(1): 111 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Nestel, H. Shige, S. Pomeroy, M. Cehun, and J. Chin-Dusting Post-prandial remnant lipids impair arterial compliance J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1929 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Paolisso, D. Manzella, M. R. Tagliamonte, M. Barbieri, R. Marfella, G. Zito, M. Bonafè, D. Giugliano, C. Franceschi, and M. Varricchio The BB-Paraoxonase Genotype Is Associated with Impaired Brachial Reactivity after Acute Hypertriglyceridemia in Healthy Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1078 - 1082. [Abstract] [Full Text] |
||||
![]() |
K. Polak, L. Schmetterer, A. Luksch, S. Gruber, E. Polska, V. Peternell, M. Bayerle-Eder, M. Wolzt, M. Krebs, and M. Roden Free fatty acids/triglycerides increase ocular and subcutaneous blood flow Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R56 - R61. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Naghavi, Z. Barlas, S. Siadaty, S. Naguib, M. Madjid, and W. Casscells Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction Circulation, December 19, 2000; 102(25): 3039 - 3045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Vogel, M. C. Corretti, and G. D. Plotnick The postprandial effect of components of the mediterranean diet on endothelial function J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1455 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Hodis Myocardial Ischemia and Lipoprotein Lipase Activity Circulation, October 3, 2000; 102(14): 1600 - 1601. [Full Text] [PDF] |
||||
![]() |
J. J. P. Kastelein, J. W. Jukema, A. H. Zwinderman, S. Clee, A. J. van Boven, H. Jansen, T. J. Rabelink, R. J. G. Peters, K. I. Lie, G. Liu, et al. Lipoprotein Lipase Activity Is Associated With Severity of Angina Pectoris Circulation, October 3, 2000; 102(14): 1629 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fard, C. H. Tuck, J. A. Donis, R. Sciacca, M. R. Di Tullio, H. D. Wu, T. A. Bryant, N.-T. Chen, M. Torres-Tamayo, R. Ramasamy, et al. Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2039 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Raitakari, N. Lai, K. Griffiths, R. McCredie, D. Sullivan, and D. S. Celermajer Enhanced peripheral vasodilation in humans after a fatty meal J. Am. Coll. Cardiol., August 1, 2000; 36(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. de Man, A. W. E. Weverling-Rijnsburger, A. van der Laarse, A. H. M. Smelt, J. W. Jukema, and G. J. Blauw Not Acute but Chronic Hypertriglyceridemia Is Associated With Impaired Endothelium-Dependent Vasodilation : Reversal After Lipid-Lowering Therapy by Atorvastatin Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. P. Skyrme-Jones, R. C. O'Brien, M. Luo, and I. T. Meredith Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes J. Am. Coll. Cardiol., February 1, 2000; 35(2): 292 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vehkavaara, S. Makimattila, A. Schlenzka, J. Vakkilainen, J. Westerbacka, and H. Yki-Jarvinen Insulin Therapy Improves Endothelial Function in Type 2 Diabetes Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 545 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. New, S. J. Duffy, R. W. Harper, and I. T. Meredith Estrogen improves acetylcholine-induced but not metabolic vasodilation in biological males Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2341 - H2347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stein, J. G. Keevil, D. A. Wiebe, S. Aeschlimann, and J. D. Folts Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease Circulation, September 7, 1999; 100(10): 1050 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Duffy, G. New, R. W Harper, and I. T Meredith Metabolic vasodilation in the human forearm is preserved in hypercholesterolemia despite impairment of endothelium-dependent and independent vasodilation Cardiovasc Res, August 15, 1999; 43(3): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Schnell, A. Robertson, D. Houston, L. Malley, and T. J. Anderson Impaired brachial artery endothelial function is not predicted by elevated triglycerides J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2038 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, R. J. Walker, and G. T. Wilkins Impaired endothelial function following a meal rich in used cooking fat J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1050 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kaufman, G. D. Plotnick, M. C. Corretti, and R. A. Vogel Effect of Vitamins C and E on Vascular Reactivity JAMA, April 8, 1998; 279(14): 1069 - 1070. [Full Text] [PDF] |
||||
![]() |
Antioxidants and High-Fat Meals Journal Watch Dermatology, January 1, 1998; 1998(101): 19 - 19. [Full Text] |
||||
![]() |
ANTIOXIDANT EFFECTS NEUTRALIZE SHORT-TERM EFFECTS OF HIGH FAT MEALS Journal Watch (General), December 9, 1997; 1997(1209): 2 - 2. [Full Text] |
||||
![]() |
F. Bohm, G. Ahlborg, B.-L. Johansson, L.-O. Hansson, and J. Pernow Combined Endothelin Receptor Blockade Evokes Enhanced Vasodilatation in Patients With Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 674 - 679. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |